Dexamisole

This classification denotes an antihelminthic agent with the molecular formula C11H12N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, UMH46V5U01 chemically known as (+)-2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazole but generally known as dexamisole, which bears US NIH Compound Identifier 66374. European Medicines Agency schedules Dexamisole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07020MIG. The term DEXAMISOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, no. 10 1974, list 14. ). Most nations schedule dexamisole under HS 29349990 and SITC 51579. As of Q4 2014, DEXAMISOLE remains the US FDA Preferred Term for this commodity. Dexamisole bears US NLM identifiers UMLS ID C0057604 and NCI Concept Code C78042. SMILES: C1CSC2=NC(CN21)C3=CC=CC=C3.